Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedema

BACKGROUND: Hereditary angioedema (HAE) is a rare genetic disorder characterized by unpredictable localized episodes of edema, which is frequently managed with long-term prophylactic medications. Until recently, long-term prophylaxis has predominantly required regular intravenous or subcutaneous adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Gower, Richard G., Wilber, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501591/
https://www.ncbi.nlm.nih.gov/pubmed/34627358
http://dx.doi.org/10.1186/s13223-021-00603-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501591/
https://www.ncbi.nlm.nih.gov/pubmed/34627358
http://dx.doi.org/10.1186/s13223-021-00603-9

Ejemplares similares